BAR HARBOR — The MDI Biological Laboratory (MDIBL) has named James S. Strickland as director of MDI Bioscience, a new initiative focused on using non-mammalian models in early drug discovery and development.
Strickland brings a wealth of pharmaceutical development experience to his new position, in which he will leverage the MDI Biological Laboratory’s 124-year history of using non-mammalian animal models such as zebrafish and C. elegans for scientific research to fill a need in pharmaceutical discovery and development for pre-clinical models that bridge the gap between isolated systems such as cell cultures and mammals such as the mouse or rat. Read more
